Literature DB >> 13129800

Molecular and cellular basis of spinal muscular atrophy.

Sibylle Jablonka1, Michael Sendtner.   

Abstract

Autosomal recessive spinal muscular atrophy (SMA) is a neuromuscular disorder characterized by muscle atrophy combined with motor neuron degeneration. SMA is caused by homozygous mutation or loss of the telomeric copy of the survival of motor neuron gene (SMN). The SMN gene is localized as an inverted repeat on chromosome 5q13. Both gene copies (SMN1 and SMN2) are expressed, but they differ in the expression of full-length protein. SMN2 gene preferentially gives rise to a truncated and less stable version of the SMN protein and thus can not compensate for SMN1 loss or mutations unless it is not present in multiple copies. The SMN protein is part of multiprotein complexes in the cytoplasm and the nucleus of all cell types. These complexes are involved in assembly of spliceosomal snRNPs. SMN interacts with RNA polymerase II and other binding proteins, indicating that the SMN protein is involved in messenger and ribosomal RNA transcription and processing. The analysis of animal models for SMA could help to identify the pathophysiological changes that are responsible for spinal muscular atrophy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129800     DOI: 10.1080/14660820310011296

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  7 in total

1.  Gemin5 Binds to the Survival Motor Neuron mRNA to Regulate SMN Expression.

Authors:  Eileen Workman; Caitlin Kalda; Aalapi Patel; Daniel J Battle
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

Review 2.  Mechanisms for axon maintenance and plasticity in motoneurons: alterations in motoneuron disease.

Authors:  Sibylle Jablonka; Benjamin Dombert; Esther Asan; Michael Sendtner
Journal:  J Anat       Date:  2013-09-06       Impact factor: 2.610

3.  Identification of novel compounds that increase SMN protein levels using an improved SMN2 reporter cell assay.

Authors:  Jonathan J Cherry; Matthew C Evans; Jake Ni; Gregory D Cuny; Marcie A Glicksman; Elliot J Androphy
Journal:  J Biomol Screen       Date:  2012-01-10

4.  Fibroblast growth factor-2 regulates the stability of nuclear bodies.

Authors:  Alexander-Francisco Bruns; Jeroen van Bergeijk; Christina Lorbeer; Anna Nölle; Julia Jungnickel; Claudia Grothe; Peter Claus
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

Review 5.  Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Authors:  K R Sabitha; Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989

6.  Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds.

Authors:  Jonathan J Cherry; Erkan Y Osman; Matthew C Evans; Sungwoon Choi; Xuechao Xing; Gregory D Cuny; Marcie A Glicksman; Christian L Lorson; Elliot J Androphy
Journal:  EMBO Mol Med       Date:  2013-06-05       Impact factor: 12.137

7.  Super-Resolution Microscopy Reveals Presynaptic Localization of the ALS/FTD Related Protein FUS in Hippocampal Neurons.

Authors:  Michael Schoen; Jochen M Reichel; Maria Demestre; Stefan Putz; Dhruva Deshpande; Christian Proepper; Stefan Liebau; Michael J Schmeisser; Albert C Ludolph; Jens Michaelis; Tobias M Boeckers
Journal:  Front Cell Neurosci       Date:  2016-01-12       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.